Literature DB >> 7643141

Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins.

R Kaiser1.   

Abstract

Cerebrospinal fluid (CSF) and serum samples of 47 patients with serologically proven neuroborreliosis were examined by Western blotting for antibodies to a crude extract of human cortex (CNS) comprising a multitude (> 40) of protein bands. Intrathecal synthesis of total immunoglobulins was determined by the Reiber formula and of autoantibodies to CNS proteins by enzyme-linked immunoassay (ELISA) and by Western blotting. Employing ELISA, intrathecal synthesis of autoantibodies (IgG, IgM and/or IgA) was demonstrated in 40 of 47 patients with neuroborreliosis (85%), in 5 of 40 with multiple sclerosis (12%), and in 22 of 40 with viral meningoencephalitis (55%). Of 40, 35 and 15 patients with neuroborreliosis and an intrathecal synthesis of total IgG, IgM or IgA, 20 revealed an intrathecal production of IgG antibodies (50%), 24 of IgM antibodies (68%) and 6 of IgA autoantiodies (40%) in the CSF. The specificity of autoantibodies differed greatly between most patients. Of 24 different CNS proteins which elicited an immune response in various patients, identities could be determined only for the myelin basic protein (5 of 40) and for the three neurofilament proteins (NF-68, NF-150, NF-200) (13 of 40 patients). In this limited number of patients no significant correlation between individual clinical symptoms and certain autoantiodies could be detected. The higher frequency of intrathecally produced autoantibodies in patients with neuroborreliosis is assumed to result from mitogenic rather than specific activation of autoreactive B-cell clones by Borrelia burgdorferi. The pathogenic relevance of these autoantibodies remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643141     DOI: 10.1007/bf00878875

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features.

Authors:  W Kristoferitsch; E Sluga; M Graf; H Partsch; R Neumann; G Stanek; H Budka
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  [Vasculitic neuropathy in the Garin-Bujadoux-Bannwarth syndrome. A contribution to the understanding of the pathology and pathogenesis of the neurological complications in Lyme borreliosis].

Authors:  C Meier; H Grehl
Journal:  Dtsch Med Wochenschr       Date:  1988-01-29       Impact factor: 0.628

3.  Antibodies to myelin basic protein in Lyme disease.

Authors:  J C Garcia-Monco; J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

4.  Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.

Authors:  T Olsson; S Baig; B Höjeberg; H Link
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

5.  Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis.

Authors:  S Baig; T Olsson; B Höjeberg; H Link
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

6.  Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  K Hansen; M Cruz; H Link
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

Review 7.  The forces driving autoimmune disease.

Authors:  I M Roitt; P R Hutchings; K I Dawe; N Sumar; K B Bodman; A Cooke
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

8.  Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.

Authors:  R Schoenfeld; B Araneo; Y Ma; L M Yang; J J Weis
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS.

Authors:  C H Chou; W W Tourtellotte; R F Kibler
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

10.  Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals.

Authors:  K Stefansson; L S Marton; M E Dieperink; G K Molnar; W W Schlaepfer; C M Helgason
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  5 in total

1.  Targeting CXCL13 During Neuroinflammation.

Authors:  Amanda K Huber; David N Irani
Journal:  Adv Neuroimmune Biol       Date:  2015-11-13

Review 2.  Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review.

Authors:  M Wilke; H Eiffert; H J Christen; F Hanefeld
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

3.  Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis.

Authors:  Sandra Kuenzle; Hans-Christian von Büdingen; Mirjam Meier; Melanie D Harrer; Eduard Urich; Burkhard Becher; Norbert Goebels
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

4.  A case of relapsing-remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis.

Authors:  P Albrecht; N Henke; H C Lehmann; S Macht; H Hefter; N Goebels; C Mackenzie; T A Rupprecht; V Fingerle; H P Hartung; A Methner
Journal:  Case Rep Neurol       Date:  2012-03-14

5.  Regulated Production of CXCL13 within the Central Nervous System.

Authors:  David N Irani
Journal:  J Clin Cell Immunol       Date:  2016-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.